The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion

PURPOSE: The purpose of this study was to evaluate the in-use physicochemical and biological stability of the Sandoz rituximab biosimilar, marketed under the trade names Rixathon® and Riximyo® in the European Union, upon preparation for intravenous infusion. METHODS: Three batches of Rixathon®/Rixim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamanna, William C, Heller, Katharina, Schneider, Daniel, Guerrasio, Raffaele, Hampl, Veronika, Fritsch, Cornelius, Schiestl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348458/
https://www.ncbi.nlm.nih.gov/pubmed/28950806
http://dx.doi.org/10.1177/1078155217731506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348458/
https://www.ncbi.nlm.nih.gov/pubmed/28950806
http://dx.doi.org/10.1177/1078155217731506

Ejemplares similares